Early diagnosis and stage-adapted treatment of Wegener's granulomatosis

Journal of Laryngology and Otology

Volumn 117, Issue 3, 2003, Pages 208-211

  Cadoni, Gabriella ^a   Agostino, S ^a   Campobasso, E ^a   Vulpiani, P ^a   Manna, R ^a   Galli, J ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antibodies, Antineutrophil Cytoplasmic; Facial Paralysis; Hearing Loss, Bilateral; Wegener's Granulomatosis

Indexed keywords

ANTIBODY; CYCLOPHOSPHAMIDE; ENDOTHELIAL CELL ANTIBODY; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; STEROID; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG EFFICACY; FACIAL NERVE PARALYSIS; FACIAL NERVE SURGERY; HEARING LOSS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; OTITIS MEDIA; RELAPSE; REMISSION; WEGENER GRANULOMATOSIS;

EID: 0037335246     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1258/002221503321192539     Document Type: Article

References (23)

1. Illum P, Thorling K. Wegener's granulomatosis long term results of treatment. Ann Otol Rhinol Laryngol 1981;90:231-4
2. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85
3. Cohen T, Huitema MG, Henè RJ, Sluiter WJ, The TH, van der Hem GK, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on anti-neutrophil cytoplasmic antibody titre. Lancet 1990;336:709-11
4. Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes DM, et al. Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med 1992;302:427-38
5. Lebovics RS, Hoffman GS, Leavitt RY, Kerr GS, Travis WD, Kammerer W, et al. The management of subglottic stenosis in patients with Wegener's granulomatosis. Laryngoscope 1992;102:1341-5
6. Gobel U, Eichlam J, Kettritz R, Briedigkeit L, Sima D, Lindschov C, et al. Disease activity and autoantibodies to endothelial cells in patients with Wegener's granulomatosis. Am J Kidney Dis 1996;28:186-94
7. Calonius IJ, Christensen CK. Hearing impairment and facial palsy as initial signs of Wegener's granulomatosis. J Laryngol Otol 1980;94:649-57
8. Dagum P, Roberson JB. Otologic Wegener's granulomatosis with facial nerve palsy. Ann Otol Rhinol Laryngol 1998;107:555-9
9. Hern JD, Hollis LJ, Moshloulis G, Montgomery PQ, Tolley NS. Early diagnosis of Wegener's granulomatosis presenting with facial nerve palsy. J Laryngol Otol 1996;110:459-61
10. Hofmann T, Kainz J, Koc C, Smolle KH, Brunner G. Isolierte einseitige otitis mit fazialisparese als erstsymptom bei Wegener-granulomatose. Ein ungewoehnlicher klinischer Verlauf. Laryngo-Rhino-Otol 1998;77:352-4
11. Illum P, Thorling K. Otological manifestation of Wegener's granulomatosis. Laryngoscope 1982;92:801-4
12. Kornblut AD, Wolff SM, Fauci AS. Ear disease in patients with Wegener's granulomatosis. Laryngoscope 1982;92:713-7
13. Macias JD, Wackym PA, McCabe BF. Early diagnosis of otologic Wegener's granulomatosis using the serologic marker c-ANCA. Ann Otol Rhinol Laryngol 1993;102:337-41
14. McCaffrey TV, McDonald TJ, Facer GW, DeRemee RA. Otologic manifestations of Wegener's granulomatosis. Otolaryngol Head Neck Surg 1980;88:586-93
15. Moussa AE, Abou-Elhmd KA. Wegener's granulomatosis presenting as mastoiditis. Ann Otol Rhinol Laryngol 1998;107:560-3
16. Nishino H, Rubino FA, DeRemee RA, Swansin JW, Parisi JE. Neurologic involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993;33:4-9
17. Nikolaou AC, Vlachtsis KC, Daniilidis MA, Petridis DG, Daniilidis IC. Wegener's granulomatosis presenting with bilateral facial nerve palsy. Eur Arch Otorhinolaryngol 2001;258:198-202
18. Propzotnik S, Razman B, Blank M, Shoenfeld Y. Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis. Wien Klin Wochenschr 2000;12:660-4
19. Davenport A. False positive perinuclear and cytoplasmatic anti-neurophil cytoplasmatic antibody results leading to misdiagnosis of Wegener's granulomatosis and or microscopic polyarteritis. Clin Nephrol 1992;37:124-30
20. Carrie S, Hughes K, Watson MG. Negative ANCA in Wegener's granulomatosis. J Laryngol Otol 1994;108:420-2
21. Rahman MU, Poe DS, Choi HK. Etanercept therapy for immune-mediate cochleovestibular disorders: preliminary results in a pilot study. Otol Neurol 2001;22:619-24
22. Rasmussen N. Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist's perspective. Curr Opin Rheumatol 2001;13:3-11
23. Thomas-Golbanov C, Sridharan S. Novel therapies in vasculitis. Expert Opin Investig Drugs 2001;10:1279-89